ArkAb company is now created!

The company ArkAb is now created as B Cell Design subsidiary! ArkAb remain focused on developing chimeric antibodies for in vitro diagnostics and research markets. B Cell Design keeps its activity of developing innovative therapeutic candidates.

Go back

This website uses cookies, by continuing to browse this website you agree to our cookie policy.